Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking

Cancer Science

Volumn 99, Issue 4, 2008, Pages 787-791

  Wang, Haijian ^a   Liu, Yang ^a   Tan, Wen ^b   Zhang, Yang ^a   Zhao, Naiqing ^a   Jiang, Yan ^a   Lin, Chengzhao ^a   Hao, Bingtao ^c   Zhao, Dan ^b   Qian, Ji ^a   Lu, Daru ^a   Jin, Li ^a   Wei, Qingyi ^d   Lin, Dongxin ^b   He, Fuchu ^a  

^a FUDAN UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE LYSINE METHYLTRANSFERASE; PROTEIN SMYD 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SMOKING; SQUAMOUS CELL CARCINOMA; TANDEM REPEAT;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SMOKING; TANDEM REPEAT SEQUENCES;

EID: 41349105728     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00729.x     Document Type: Article

References (29)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 55: 891-903.
2. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-99. Int J Cancer 2003; 106: 771-83.
3. Gao YT, McLaughlin JK, Blot WJ et.al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994; 58: 192-6.
4. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-13.
5. Gibbons RJ. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet.: 14 Spec, 2005; 1: R85-92.
6. Ozdag H, Teschendorff AE, Ahmed AA et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 2006; 7: 90.
7. Tan W, Song N, Wang GQ et al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 551-6.
8. Hao B, Wang H, Zhou K et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004; 64: 4378-84.
9. Smeds J, Berggren P, Ma X, Xu Z, Hemminki K, Kumar R. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus. the CDKN2A (p16 (INK4a) and p14 (ARF) and p53 genes are major targets for inactivation. Carcinogenesis 2002; 23: 645-55.
10. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 2004; 96: 1030-6.
11. Sun T, Gao Y, Tan W et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007; 39: 605-13.
12. Dillon SC, Zhang X, Trievel RC, Cheng X. The SET-domain protein superfamily: Protein lysine methyltransferases. Genome Biol 2005; 6: 227.
13. Hamamoto R, Furukawa Y, Morita M et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004; 6: 731-40.
14. Sims RJ 3rd, Reinberg D. From chromatin to cancer: A new histone lysine methyltransferase enters the mix. Nat Cell Biol 2004; 6: 685-7.
15. Spadaccini R, Perrin H, Bottomley MJ, Ansieau S, Sattler M. Structure and functional analysis of the MYND domain. J Mol Biol 2006; 358: 498-508.
16. Liu C, Fang X, Ge Z et al. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res 2007; 67: 2626-31.
17. Tsuge M, Hamamoto R, Silva FP et.al. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers. Nat Genet 2005; 37: 1104-7.
18. Frank B, Hemminki K, Wappenschmidt B et al. Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. Int J Cancer 2006; 118: 2917-8.
19. Wang XQ, Miao X, Cai Q, Garcia-Barcelo MM, Fan ST. SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population. Exp Oncol 2007; 29: 71-3.
20. Brennan P. Gene-environment interaction and aetiology of cancer: What does it mean and how can we measure it? Carcinogenesis 2002; 23: 381-7.
21. Hamamoto R, Silva FP, Tsuge M et al. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci 2006; 97: 113-8.
22. Yoon KA, Hwangbo B, Kim IJ et al. Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer. Carcinogenesis 2006; 27: 2217-22.
23. Bachmann N, Hoegel J, Haeusler J et al. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer. Prostate 2005; 65: 252-9.
24. Marsit CJ, Karagas MR, Danaee H et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006; 27: 112-6.
25. Kim DH, Nelson HH, Wiencke JK et al. p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61: 3419-24.
26. Kraunz KS, Nelson HH, Lemos M, Godleski JJ, Wiencke JK, Kelsey KT. Homozygous deletion of p16 (INK4a) and tobacco carcinogen exposure in nonsmall cell lung cancer. Int J Cancer 2006; 118: 1364-9.
27. Lockett KL, Hall MC, Xu J et.al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 6344-8.
28. Zhang X, Miao X, Liang G et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res, 2005; 65: 722-6.
29. Hung RJ, Brennan P, Canzian F et.al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005; 97: 567-76.